Can Heartflow, Inc. Common Stock cover its short-term obligations?

Its current ratio is 5.57 — current assets exceed current liabilities.

Where does Heartflow, Inc. Common Stock's balance sheet data come from?

Every line is extracted from Heartflow, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Heartflow, Inc. Common Stock HTFL Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$24.37M-50.7%	$49.49M-83.3%	$295.64M+249%	$84.69M-25.9%	$114.26M—
Short-term investments	——	——	——	——	——
Restricted cash	$4.7M-0.1%	$4.71M—	$0—	$0-100%	$4.48M—
Accounts receivable, net	$122.42M+35.3%	$90.49M+5.5%	$85.79M+45.7%	$58.89M+95.2%	$30.16M+9.6%
Prepaid expenses and other current assets	$49.37M+55.3%	$31.79M+33.3%	$23.85M+55.5%	$15.34M+118%	$7.04M+2.3%
Trading assets	——	——	——	——	——
Derivative assets	——	$0—	——	——	——
Total current assets	$211.83M—	——	——	——	——
Property and equipment, net	$9.83M—	——	——	——	——
Accumulated depreciation	$13.93M—	——	——	——	——
Operating lease right-of-use assets	8.7%—	——	——	——	——
Deferred tax assets	——	——	——	——	——
Other non-current assets	$1.6M—	——	——	——	——
Equity method investments	——	——	——	——	——
Long-term investments	——	——	——	——	——
Allowance for credit losses	——	——	——	——	——
Total assets	$344.03M—	——	——	——	——
Accounts payable	$12.66M+140%	$5.29M+6.0%	$4.99M+69.2%	$2.95M+173%	$1.08M-58.9%
Accrued expenses	$19.76M—	——	——	——	——
Deferred revenue	$1.58M—	——	——	——	——
Operating lease liabilities, current	$6.38M—	——	——	——	——
Contract liabilities	$386K—	——	——	——	——
Accrued interest	——	——	——	——	——
Total current liabilities	$38.02M—	——	——	——	——
Deferred tax liabilities	——	——	——	——	——
Operating lease liabilities, non-current	$19.97M—	——	——	——	——
Operating Lease Liabilities (Total)	$26.35M—	——	——	——	——
Other non-current liabilities	$322K—	——	——	——	——
Total liabilities	$58.31M—	——	——	——	——
Common stock	$250M—	——	——	——	——
Additional paid-in capital	$1.4B—	——	——	——	——
Retained earnings	-$1.12B—	——	——	——	——
Accumulated other comprehensive income (loss)	-$685K—	——	——	——	——
Total stockholders' equity	$285.72M-5.0%	$300.65M+18.1%	$254.57M+128%	-$894.8M-0.7%	-$889M-3.4%
Total liabilities and stockholders' equity	$344.03M—	——	——	——	——
Available-for-Sale Debt Securities - Amortized Cost	——	——	——	——	——
Available-for-Sale Debt Securities - Fair Value by Maturity	——	——	——	——	——
Available-for-Sale Debt Securities - Single Maturity Date	——	——	——	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	——	——	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position Fair Value	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	——	——	——	——
Allowance for Doubtful Accounts	$626K—	——	——	——	——
Allowance for Doubtful Accounts Receivable (Current)	$626K—	——	——	——	——
Capitalized Contract Costs, Current	$8.2M—	——	——	——	——
Cash, Cash Equivalents, and Marketable Securities	——	——	——	——	——
Deferred costs	$8.2M—	——	——	——	——
Cash Cash Equivalents And Short Term Investments	——	——	——	——	——
Other current assets	$1.47M—	——	——	——	——
Unbilled Revenue	$835K—	——	——	——	——
Capitalized Contract Costs, Net	$13.27M—	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$6.68M—	——	——	——	——
Indefinite-Lived Research and Development Assets	——	——	——	——	——
Investments - Amortized Cost Basis	——	——	——	——	——
Net Investment in Lease	$14.41M—	——	——	——	——
Deferred costs	$5.07M—	——	——	——	——
Investments	——	——	——	——	——
Investments	——	——	——	——	——
Operating lease right-of-use assets	$14.41M—	——	——	——	——
Other non-current assets	$6.68M—	——	——	——	——
Property, plant and equipment at cost	$23.76M—	——	——	——	——
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	——	——	——	——	——
Operating Lease Right-of-Use Assets in Other Assets	$14.41M—	——	——	——	——
Software and Technology Licenses, Net	$6.68M—	——	——	——	——
Tax Credit Carryforward Valuation Allowance	——	——	——	——	——
Accrued Contingent Liabilities	$0—	——	——	——	——
Accrued Manufacturing Costs	$19.76M—	——	——	——	——
Accrued Royalties (Current)	$1.05M—	——	——	——	——
Compensation and benefits	$19.76M—	——	——	——	——
Derivative Liabilities - Fair Value	——	$0-100%	$24.6M—	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	$7.07M—	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	$5.15M—	——	——	——	——
Lease Liability Payments - Due Year Two	$7.07M—	——	——	——	——
Lease Liability Payments - Due Year Three	$6.81M—	——	——	——	——
Lease Liability Payments - Due Year Four	$5.15M—	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	$6.85M—	——	——	——	——
Operating Lease Liability Payments Due	$31.61M—	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	$5.26M—	——	——	——	——
Professional Service Fees Payable	$821K—	——	——	——	——
Deferred Tax Liabilities - Leasing Arrangements	——	——	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	$6.81M—	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	$6.81M—	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	$5.15M—	——	——	——	——
Operating Lease Liability Payments - 2029 (Lessee)	——	——	——	——	——
Accrued expenses and other liabilities	$25.89M—	——	——	——	——
Total debt	$26.35M—	——	——	——	——
Unrecognized Deferred Tax Liability on Undistributed Foreign Earnings	——	——	——	——	——
Unrecognized Tax Benefits	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	——	——	——	——	——
Common Stock Par Value Per Share	$0.00—	——	——	——	——
Common Stock Shares Issued	$86.11M—	——	——	——	——
Common Stock Shares Outstanding	$150.61M—	——	——	——	——
Convertible Preferred Stock Authorized Shares	——	——	——	——	——
Convertible Preferred Stock Issued Shares	——	——	——	——	——
Convertible Preferred Stock Outstanding Shares	——	——	——	——	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$86K—	——	——	——	——
Investments - Gross Unrealized Losses	——	——	——	——	——
Number of Exercisable Options	$82.46M—	——	——	——	——
Number of Vested and Expected to Vest Options	$150.61M—	——	——	——	——
Preferred Stock Par Value Per Share	——	——	——	——	——
Share-Based Payment Award Options Outstanding - Number	$10.23M—	——	——	——	——
Share-Based Payment - Unrecognized Cost of Nonvested Awards	$40.9M—	——	——	——	——
Shares Reserved for Future Issuance Under Stock Plans	$23.72M—	——	——	——	——
Undistributed Earnings of Foreign Subsidiaries	——	——	——	——	——
Unrealized Gains on Investments	——	——	——	——	——
Unrealized Losses on Investments (Before Tax)	——	——	——	——	——
Warrants and Rights Outstanding	——	——	——	——	——
Weighted Average Exercise Price of Exercisable Options	5.6—	——	——	——	——
Weighted Average Exercise Price of Outstanding Options	9.9—	——	——	——	——
Weighted Average Exercise Price of Vested and Expected to Vest Options	9.9—	——	——	——	——
Cumulative Cost Basis	$241.64M—	——	——	——	——
Gross Assets/Liabilities	——	$0—	——	——	——
Accrued Clinical Trial Expenses Current	$1.12M—	——	——	——	——
Professional service fees	$821K—	——	——	——	——
Licensing Arrangements	$1.05M—	——	——	——	——
Accounts Receivable, Allowance for Credit Loss	$626K—	——	——	——	——
Allowance for doubtful accounts	——	——	——	——	——
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	——	——	——	——	——
Gross Unrealized Gains	——	——	——	——	——
Total	——	——	——	——	——
Available For Sale Securities Debt Maturities After One Through Two Years Fair Value	——	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——	——
Available for sale investments	——	——	——	——	——
Capitalized Contract Cost, Net	$13.27M—	——	——	——	——
Common stock, capital shares reserved for future issuance	$23.72M—	——	——	——	——
Common stock, par value (in dollars per share)	$0—	——	——	——	——
Common stock, shares authorized (in shares)	$250M—	——	——	——	——
Common stock, shares issued (in shares)	$86.11M—	——	——	——	——
Common Stock, Shares, Outstanding	$86.11M—	——	——	——	——
Contract with Customer, Liability	$386K—	——	——	——	——
Other Contractual Commitments	$50K—	——	——	——	——
Contractual Obligation, to be Paid, Year Four	$50K—	——	——	——	——
Contractual Obligation, to be Paid, Year Two	$50K—	——	——	——	——
Contractual Obligation, to be Paid, Year Three	$50K—	——	——	——	——
Debt Securities, Available-for-Sale, Allowance for Credit Loss	——	——	——	——	——
Less than 12 months	——	——	——	——	——
12 months or more	——	——	——	——	——
Debt Securities, Available-for-Sale, Unrealized Loss Position	——	——	——	——	——
Deferred Tax Liabilities, Gross	——	——	——	——	——
Disallowed business interest expense carryforward	——	——	——	——	——
Deferred Tax Assets, Gross	——	——	——	——	——
Deferred Tax Assets, Net	——	——	——	——	——
Deferred Tax Assets, Net of Valuation Allowance	——	——	——	——	——
Deferred Tax Assets Operating Lease Liabilities	——	——	——	——	——
Deferred Tax Assets, Operating Loss Carryforwards	——	——	——	——	——
Deferred Tax Assets Property Plant And Equipment And Intangible Assets	——	——	——	——	——
R&D credit carryforward	——	——	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost	——	——	——	——	——
Temporary differences related to Texas Margin Tax	——	——	——	——	——
Deferred Tax Assets, Valuation Allowance	——	——	——	——	——
Deferred Tax Liabilities Capitalized Contract Costs	——	——	——	——	——
Deferred Tax Liabilities, Other	——	——	——	——	——
Deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested	——	——	——	——	——
Derivative Liability	——	$0—	——	——	——
Cost not yet recognized	$40.9M—	——	——	——	——
Income tax adjustments	——	——	——	——	——
Lessee Operating Lease Liability Payments Due	$31.61M—	——	——	——	——
Lessee Operating Lease Liability To Be Paid After Year Four	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	$5.26M—	——	——	——	——
Loss Contingency Accrual	$0—	——	——	——	——
Operating Lease Weighted Average Discount Rate Percent	$0.09—	——	——	——	——
Other accrued liabilities	$1.55M—	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	——	——	——	——	——
Preferred Stock, Shares Authorized	——	——	——	——	——
Preferred Stock, Shares Issued	——	——	——	——	——
Preferred Stock, Shares Outstanding	——	——	——	——	——
Prepaid expenses	$8.31M—	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$9.94—	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$10.23M—	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	$10.23M—	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$150.61M—	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$9.94—	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	$82.46M—	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$150.61M—	——	——	——	——
Unbilled Receivables	$835K—	——	——	——	——
Undistributed Earnings of Foreign Subsidiaries	——	——	——	——	——
Unrecognized tax benefits	——	——	——	——	——
Purchase Obligation	$250K—	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Unrecorded Unconditional Purchase Obligation - Due After Year Five	$50K—	——	——	——	——
Unrecorded Unconditional Purchase Obligation - Due Year Five	$50K—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Heartflow, Inc. Common Stock cover its short-term obligations?: Its current ratio is 5.57 — current assets exceed current liabilities.
Where does Heartflow, Inc. Common Stock's balance sheet data come from?: Every line is extracted from Heartflow, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.